HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Reynolds, N. C. Articles by Miska, R. M. Search for Related Content PubMed PubMed Citation Articles by Reynolds, N. C., Jr. Articles by Miska, R. M.

Human brain, plasma, and cerebrospinal fluid concentration of sodium valproate after 72 hours of therapy

Department of Neurology (Drs. Vajda, Donnan, and Bladin) and Clinical Pharmacology (Dr. Vajda and Ms. Phillips), University of Melbourne, Austin Hospital, Heidelberg, Australia.

Nine neurosurgical patients suffering from a variety of brain tumors were studied. Sodium valproate was given for 3 days before surgery. At craniotomy, sections of brain and samples of cerebrospinal fluid (CSF) and plasma were obtained and assayed for sodium valproate concentrations. Brain levels were 6.8 to 27.9% of plasma concentrations, and CSF levels were 7.6 to 25.0% of plasma levels. There was a significant correlation between brain and CSF levels and plasma on Spearman ranking. These results confirm that valproate is not selectively concentrated in brain fractions, and the concentration in brain is related to the free anticonvulsant level in plasma.

Addreas correspondence and reprint requests to Dr. Vajda, Department of Neurology, Austin Hospital, Heidelberg, Victoria 3084, Australia.

Accepted for publication June 13, 1980.

This article has been cited by other articles:

				V. S. Gopaul, W. Tang, K. Farrell, and F. S. Abbott Amino Acid Conjugates: Metabolites of 2-Propylpentanoic Acid (Valproic Acid) in Epileptic Patients Drug Metab. Dispos., January 1, 2003; 31(1): 114 - 121. [Abstract] [Full Text] [PDF]

				J. L. Scism, K. M. Powers, A. A. Artru, A. C. Chambers, L. Lewis, K. K. Adkison, T. F. Kalhorn, and D. D. Shen Effects of Probenecid on Brain-Cerebrospinal Fluid-Blood Distribution Kinetics of E-Delta 2-Valproic Acid in Rabbits Drug Metab. Dispos., December 1, 1997; 25(12): 1337 - 1346. [Abstract] [Full Text]

				A. W. Wamil, W. Löscher, and M. J. McLean Trans-2-en-valproic Acid Limits Action Potential Firing Frequency in Mouse Central Neurons in Cell Culture J. Pharmacol. Exp. Ther., March 1, 1997; 280(3): 1349 - 1356. [Abstract] [Full Text]